EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.
Molecular Diagnostics a Natural Fit for Breast Cancer
The growing global incidence of breast cancer has led to an increased demand for molecular diagnostics tests that aid in diagnosing breast cancer.
Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Guiding Life Sciences Companies Along the Path to Success
Operating for over 50 years, Safeguard Scientifics is a holding company that provides capital, as well as strategic, operational and management resources for technology and life sciences companies.
Father’s Day Draws Attention to Prostate Cancer
Father’s Day is just around the corner, but many dads won’t be around to celebrate. Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among men in the U.S.
The Role of Diagnosis In Clinical Decision-Making
Before a physician can prescribe pills or recommend a therapy, the patient must be diagnosed.
[OneMedForum] Clarient Grows Along with Cancer Testing Market
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
